RXO (NYSE:RXO - Get Free Report) had its price objective cut by analysts at Morgan Stanley from $27.00 to $25.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Morgan Stanley's target price points to a potential upside of 16.29% from the stock's current price.
A number of other brokerages have also weighed in on RXO. Wells Fargo & Company cut their price objective on shares of RXO from $31.00 to $28.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 7th. Benchmark restated a "hold" rating on shares of RXO in a research note on Wednesday, January 15th. Citigroup downgraded shares of RXO from a "buy" rating to a "neutral" rating and set a $33.00 price objective for the company. in a research note on Tuesday, November 12th. The Goldman Sachs Group reissued a "neutral" rating and issued a $29.00 target price on shares of RXO in a research report on Monday, November 18th. Finally, Jefferies Financial Group dropped their price target on RXO from $33.00 to $30.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $26.46.
Get Our Latest Stock Report on RXO
RXO Stock Up 4.8 %
RXO traded up $0.99 during trading on Thursday, hitting $21.50. The stock had a trading volume of 1,455,997 shares, compared to its average volume of 1,152,934. The stock has a 50 day simple moving average of $25.59 and a two-hundred day simple moving average of $27.41. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.33 and a current ratio of 1.26. RXO has a twelve month low of $18.75 and a twelve month high of $32.82. The company has a market capitalization of $3.46 billion, a PE ratio of -10.14, a PEG ratio of 3.63 and a beta of 1.53.
RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 earnings per share for the quarter, hitting analysts' consensus estimates of $0.06. RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. On average, research analysts predict that RXO will post 0.39 earnings per share for the current year.
Institutional Investors Weigh In On RXO
Several hedge funds have recently bought and sold shares of the stock. Blue Trust Inc. grew its position in shares of RXO by 79.7% during the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company's stock valued at $27,000 after acquiring an additional 510 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of RXO in the third quarter valued at approximately $28,000. Smartleaf Asset Management LLC raised its stake in shares of RXO by 228.4% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company's stock worth $30,000 after buying an additional 868 shares during the period. Nomura Asset Management Co. Ltd. lifted its position in shares of RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company's stock valued at $39,000 after buying an additional 570 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its position in shares of RXO by 407.0% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock valued at $43,000 after buying an additional 1,445 shares in the last quarter. Hedge funds and other institutional investors own 92.73% of the company's stock.
About RXO
(
Get Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
See Also

Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.